Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) have been utilized for the treatment of head and neck or skull base paraganglioma for a considerable time, demonstrating promising local control rates and a favorable safety profile compared to surgical approaches. Nevertheless, the choice of treatment must be carefully tailored to each patient’s preferences, tumor location, and size, as well as anticipated treatment-related morbidity. This case-based review …